Prothena | PRTA - Interest Income

Stock Price
8.85
Daily Change
0.07 0.80%
Monthly
-2.75%
Yearly
-40.12%
Q1 Forecast
8.55

Prothena reported $3.35M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 7.24M 658K Jun/2025
Agios Pharmaceuticals USD 14.51M 1.57M Jun/2025
ALKERMES USD 11.09M 949K Jun/2025
Alnylam Pharmaceuticals USD 27.49M 1.19M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
BioMarin Pharmaceutical USD 18.83M 186K Jun/2025
Incyte USD 25.14M 2.21M Jun/2025
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
MacroGenics USD 1.53M 114K Sep/2025
Prothena USD 3.35M 443K Sep/2025
Regeneron Pharmaceuticals USD 175.1M 300K Sep/2025
Ultragenyx Pharmaceutical USD 5.79M 1.04M Jun/2025
Vertex Pharmaceuticals USD 122.4M 1.5M Jun/2025